Aptalis Pharmaceutical Technologies

Pharmaceutical Technologies for optimal drug delivery solutions.

Aptalis Pharmaceutical Technologies (APT) specializes in product development that leverages our proprietary Pharmaceutical Technologies . These technologies are the foundation of our business.

Click to enlarge:

Formulation Expertise

Our team of formulation experts leverage extensive experience in applying our proprietary drug delivery technologies to solve our clients’ formulation challenges.

Scale-Up

Our R&D and manufacturing processes are integrated in the U.S. and Europe facilities, allowing product scale-up and manufacturing at a single site

Global Manufacturing

Aptalis Pharmaceutical Technologies manufactures all of the products that we develop for our licensees. We are proud of our successful quality inspection rates across our multiple facilities, with expertise in hosting audits each year from various regulatory agencies from the U.S., Europe, Asia, and the Middle East.
Learn more about Manufacturing.

Licensed Product Portfolio

Aptalis Pharmaceutical Technologies has a strong track record of developing products using its proprietary drug formulation technologies, and has a number of Rx and OTC products available for licensing. We license these products to pharmaceutical companies for distribution and commercialization throughout the world.
View Licensed Product Portfolio.

We utilize these technologies to develop novel pharmaceutical and OTC products designed to have advantages over existing products or to address unmet medical needs.

Our team of formulation experts draw upon years of experience and a track record of success to meet our partners’ formulation challenges.

Integrated R&D and manufacturing teams in the U.S. and Europe support projects from formulation through scale-up, to commercial-scale manufacturing. Multiple facilities ensure that products can be efficiently distributed worldwide.

Our track record of commercialization success includes products that are marketed in more than 50 countries around the world by our partners. Specifically we have had: